Retatrutide ZPHC — 10 mg (5 vials × 2 mg)
LE 11,000.00
Skip to product information
Retatrutide ZPHC — 10 mg (5 vials × 2 mg)
LE 11,000.00
RETATRUTIDE 10 MG KIT by ZPHC PHARMA is a cutting-edge investigational peptide designed to activate three key hormonal receptors:
- GLP-1 (Glucagon-Like Peptide-1)
- GIP (Gastric Inhibitory Polypeptide)
- Glucagon Receptor
This triple-agonist peptide has demonstrated promising effects in early research studies for its ability to support weight management, enhance insulin sensitivity, and improve metabolic performance. It is intended strictly for laboratory research and non-human use.
Key Research Benefits
-
Multi-Receptor Activation
Simultaneously targets GLP-1, GIP & glucagon receptors for synergistic metabolic impact - Weight Reduction Support
Helps reduce food intake and increase fat oxidation - Glucose & Insulin Modulation
Promotes improved glycemic control and insulin function - Energy Balance
May contribute to increased energy expenditure and metabolic flexibility
Suggested Research Use (For Laboratory Purposes Only)
Retatrutide should be reconstituted with bacteriostatic water prior to subcutaneous administration.
Dosage protocols vary based on study design, species model, and target endpoints.